Putin Advances $26 Billion Russian Longevity Project Focused on Organ Replacement and Genetic Therapies
Russian President Vladimir Putin has elevated the pursuit of life extension into a major national scientific initiative valued at $26 billion. This project, revealed in 2024, aims to save 175,000 lives by 2030 through advanced treatments such as genetic therapies to slow cellular aging, 3D bioprinting of human tissues, and growing human organs inside genetically compatible miniature pigs. These efforts are part of a Kremlin-backed longevity program that Putin discussed with Chinese President Xi Jinping during a military parade in Beijing in September 2023, where he described the potential for humans to achieve near-immortality by replacing body parts.
The initiative is led by Putin’s daughter Maria Vorontsova, an endocrinologist overseeing state-funded genetics programs, and physicist Mikhail Kovalchuk, head of the Kurchatov Institute and a close ally of Putin’s family. Kovalchuk envisions a future where human bodies can be repaired and parts replaced indefinitely, though he acknowledges that true immortality remains elusive. Despite grand ambitions, independent Russian scientists note a lack of peer-reviewed publications and suggest the program’s promises remain aspirational amid international research isolation caused by sanctions.
Putin’s interest in longevity research aligns with a broader Kremlin worldview that frames scientific advancement as a civilizational struggle against the West. The program also draws on controversial figures like Vladimir Khavinson, known as "Putin’s gerontologist," who promoted peptide-based anti-aging treatments with limited scientific validation. Putin has publicly endorsed unconventional therapies such as extreme cold exposure, recommending cryotherapy to foreign leaders.
While Putin projects an image of vigorous health through public displays of physicality, his personal preoccupation with aging is evident in strict COVID-19 isolation measures and rumored cosmetic treatments. Russia’s average male life expectancy remains low at 68 years, trailing behind Western countries. The longevity initiative reflects a historic Russian fascination with combating aging, dating back to Soviet-era experiments, but faces significant scientific and demographic challenges.
This report is based on an exclusive translation of a Wall Street Journal article by Globes.
